You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Express Scripts
Harvard Business School
AstraZeneca
Medtronic

Last Updated: March 2, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Celgosivir

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Celgosivir?

Celgosivir is an investigational drug.

There have been 9 clinical trials for Celgosivir. The most recent clinical trial was a Phase 2 trial.

The most common disease conditions in clinical trials are Hepatitis C, Hepatitis A, and Hepatitis. The leading clinical trial sponsors are BioWest Therapeutics Inc, Hoechst Marion Roussel, and Singapore General Hospital.

Recent Clinical Trials for Celgosivir
TitleSponsorPhase
Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore60 Degrees Pharmaceuticals LLCPhase 1/Phase 2
Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in SingaporeDuke-NUS Graduate Medical SchoolPhase 1/Phase 2
Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in SingaporeSingapore General HospitalPhase 1/Phase 2

See all Celgosivir clinical trials

Clinical Trial Summary for Celgosivir

Top disease conditions for Celgosivir
Top clinical trial sponsors for Celgosivir

See all Celgosivir clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Express Scripts
Harvard Business School
AstraZeneca
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.